Укр
Eng
On November 4th, Legal Alliance Company with the support of the Association of Innovative Drug Manufacturers “APRaD” held the discussion club “Discussion Pharma MeetUP on Intellectual Property: Manufacturers of Innovative Drugs vs Generics Manufacturers on Bills No. 2089 and No. 2259.” Details of the discussion in the article from Apteka.ua.
The permission provided for by the law on harmonization of Ukrainian legislation with the EU law in the field of comparative advertising (draft law No. 0953) to openly compare a product with the products of a competitor in advertising can create a problem for consumers in the pharmaceutical market of Ukraine, Andrii Gorbatenko, partner at Legal Alliance Company, believes.
Trends in legal services in the field of pharmaceutical and medical law by partner Dmytro Aleshko specifically for the national rating of Yurydychna Gazeta.
A partner at Legal Alliance Company, Dmytro Aleshko, told Interfax-Ukraine agency why a gap appeared in the regulatory framework governing international procurement of medicines and medical devices from April 1st to 19th, 2020.
Vitalii Savchuk, counsel at Legal Alliance Company, comments to the Interfax-Ukraine agency on the main provisions of the bill on amending certain legislative acts to increase the availability of medicines for the population (No. 2089).
Expert opinion of Dmytro Aleshko, partner and attorney-at-law at Legal Alliance Company regarding the regulation of international procurement specifically for Interfax-Ukraine.
Taras Bezpalyy has analyzed from the perspective of defense draft law No. 10387 and proposes to divide the proposed changes into positive and negative ones.
Simplification of customs procedures and bringing them in line with the best world standards is a prerequisite for Ukraine's competitiveness in the global economic system. Read more in the review of Volodymyr Zosimov, associate at Legal Alliance Company.